Salute e Benessere

IPSEN - Buy-back programme - Art 5 of MAR - Week 34 - 2023

Aggregatedpresentationbydayandbymarket NameofissuerIdentificationcodeof issuer(Legal Entity Identifier)Day of transactionIdentificationcodeof financialinstrumentAggregated daily volume(innumber of shares)Dailyweightedaveragepriceof the purchased shares *Market(MICCode) IPSEN549300M6SGDPB4Z94P1121/08/2023FR001025915072116.35CEUXIPSEN549300M6SGDPB4Z94P1121/08/2023...
Nasdaq GlobeNewswire
29/08/2023

Coloplast A/S - Announcement no. 06/2023 – Coloplast launches offering to raise…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL. Coloplast launches offering to raise around DKK 9 billion through issue of new B shares in a directed issue and private placement Coloplast A/S (“Coloplast”) has resolved to...
Nasdaq GlobeNewswire
29/08/2023

Transactions in connection with share buy-back program

Company announcement no. 45 - 2329 August 2023 Transactions in connection with share buy-back program On 3 August 2023 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company announcement no. 38 - 23. The program will be executed in accordance with the principles of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbor rules...
Nasdaq GlobeNewswire
29/08/2023

Diagnostic Electrocardiograph (ECG) Market worth $11.3 billion |…

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173 Browse in-depth TOC on "Diagnostic Electrocardiograph (ECG) Market" 120 - Tables 45 - Figures 250 - Pages Diagnostic Electrocardiograph (ECG) Market Scope: Diagnostic ECG devices segment is expected to account for the largest share in 2022. Based on product type,...
PR Newswire
29/08/2023

SciBase appoints Pia Renaudin as Chief Executive Officer

Pia is an exceptionally well-suited candidate to implement SciBase's strategy in order to reach the company's full potential. The board is convinced that she will help in creating shareholder value. Pia is an exceptionally well-suited candidate to implement SciBase's strategy in order to reach the company's full potential. The board is convinced that she will help in creating shareholder value. Tord Lendau, Chairman of the Board at SciBase commented:" I am very pleased to welcomePia...
PR Newswire
29/08/2023

Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for…

The Company anticipates submitting the MAA in approximately the next 30-45 days. The Company plans to request that the MHRA review the MAA under the 150-business day process that the MHRA has established to accelerate the availability of new medicines for patients in the U.K. The Company anticipates submitting the MAA in approximately the next 30-45 days. The Company plans to request that the MHRA review the MAA under the 150-business day process that the MHRA has established to accelerate…
PR Newswire
29/08/2023

The Aseptic Fill Finish Manufacturing Market is projected to grow at a CAGR of…

In pursuit of both time and cost savings, as well as to mitigate the challenges associated with the stringent regulatory compliance, lack of technical expertise and access to advanced equipment, a number of drug developers prefer to outsource operations to benefit from the expertise of service providers, that claim to have the required competence and experience to provide fill / finish services in order to ensure the development of high-quality drug products. In pursuit of both time and cost...
PR Newswire
29/08/2023

Biopharma Plastics Market to Reach $14.9 Billion, Globally, by 2032 at 11.6%…

Biopharma plastic is used to give a durable, smooth finish that's resistant to UV rays and chemicals. It's also great for oxidation resistance, water repellence, and vapor permeability. Also, it has great mechanical properties. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/187320 Prime Determinants of Growth: The global biopharma plastics market is experiencing growth due to several factors such as growing demand for...
PR Newswire
29/08/2023

Evaxion announces Executive Management Changes to strengthen the AI-strategy

/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-powered immunotherapies, today announced:Evaxion has hired a new Chief Executive Officer (“CEO”) to accelerate the strategic development and execution of the vast business opportunities at hand after having matured the Company's AI platforms over the past 15 years.“We are truly proud to announce that Christian Kanstrup has accepted the role as CEO of Evaxion...
Nasdaq GlobeNewswire
29/08/2023

Huma collaborates with Google Cloud to improve healthcare through generative AI

Huma's platform gathers a wealth of real-world data that hold crucial clinical insights related to disease progression, deterioration, and potential new diagnoses. However, these insights can sometimes go unnoticed. Combining GenAI with human oversight has the potential to harness the full transformative power of this data and deliver the predictive, personalised care that will greatly benefit both health systems and patients. Huma's platform gathers a wealth of real-world data that hold...
PR Newswire
29/08/2023

ENA Respiratory Expands Leadership Team and Extends U.S. Department of Defense…

-- New $3.8 million DOD contract extension will fund non-clinical safety studies to support a three-month seasonal prophylaxis Phase 2b study in at-risk populations, comprising elderly individuals with comorbidities, including chronic lung diseases and diabetes. -- ENA Respiratory names new clinical leaders and consultants to accelerate and optimize its research and development program. SYDNEY, Australia, Aug.29, 2023(GLOBE NEWSWIRE) -- Clinical-stage pharmaceutical company ENA...
Nasdaq GlobeNewswire
29/08/2023

OKYO Pharma Limited Regains Compliance with Nasdaq Listing Minimum Market Value…

NEW YORK and LONDON, Aug.29, 2023(GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) ("OKYO" or the "Company"), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (DED) to address the significant unmet need in this multi-billion-dollar market, today announced that it received notification from the Listing Qualifications Department (the "Staff") of the Nasdaq Stock Market ("Nasdaq") notifying OKYO that…
Nasdaq GlobeNewswire
29/08/2023

Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) in Egypt

Approval of Adalimumab-EVA™ represents the second biosimilar approval under the strategic partnership between Alvotech and BioventureAlvotech (NASDAQ: ALVO) and Bioventure, a wholly owned subsidiary of GlobalOne Healthcare Holding LLC, today announced that the Egyptian Drug Authority (EDA) has approved the manufacturing and distribution of AVT02 (adalimumab) a biosimilar for Humira®, which is commonly indicated for the treatment of rheumatoid arthritis and several other inflammatory...
Nasdaq GlobeNewswire
29/08/2023

Roche's Tecentriq becomes the first subcutaneous anti-PD-(L)1 cancer…

Tecentriq subcutaneous (SC) is now approved in Great Britain for all indications of intravenous Tecentriq , including certain types of lung, bladder, breast and liver cancer, offering a faster, more convenient option to receive treatment Administered under the skin within approx. seven minutes, Tecentriq SC saves time for patients and helps conserve resources in healthcare systems 1 Evaluations by the FDA, EMA and other health authorities globally are ongoingBasel,...
Nasdaq GlobeNewswire
29/08/2023

Carbonhand is available for Veterans in the US

"We are excited and pleased to represent Bioservo for the US launch within the Department of Defense Hospitals and Veteran's Health Institutions," says Charles Coyle, founder of Trivet Medical LLC, and continues, "Carbonhand is a smart, intuitive, and revolutionary aid that gives back power to people with impaired hand function. There is no greater honor than to be of service to a member of our US Armed Forces who has given sacrifice, sustained injury, loss, or hardship. We are…
PR Newswire
29/08/2023

Serca Pharmaceuticals presents first-in-class strategy for game-changing, post…

The findings presented suggest that specifically blocking the adrenergic regulation of SERCA2-activity is beneficial and provide evidence that small molecular protein to protein interaction (PPI) disruptors with this mechanism, such as Serca's lead product 13-M, reduce infarct size and preserve cardiac function. The findings presented suggest that specifically blocking the adrenergic regulation of SERCA2-activity is beneficial and provide evidence that small molecular protein to protein...
PR Newswire
29/08/2023

For Realizing Vision of ZERO Cerebro-Cardiovascular Events, OMRON Healthcare…

A World Health Organization (WHO) report shows that the global leading cause of death is heart disease, followed by stroke. The number of cerebrovascular and cardiovascular diseases continues to rise due to the accelerating aging of the population and lifestyle changes caused by economic growth. As the Company believes the early detection of AF is a key to solve these health-related challenges, it has dedicated to communicating the importance of blood pressure control by using a home blood…
PR Newswire
29/08/2023

IFA 2023: Electrolux Group puts the spotlight on resource efficiency with AEG…

"Technological innovation is at the heart of every model within AEG EcoLine with functions designed to make life of consumers more enjoyable while making it easy to take more sustainable choices. Resource efficiency and performance without compromise is what consumers want and it's what AEG EcoLine delivers," says Chris Braam, CEO Europe Electrolux Group. "Technological innovation is at the heart of every model within AEG EcoLine with functions designed to make life of consumers…
PR Newswire
29/08/2023

New report from Essity links gender equality to global health and well-being

* UNICEF and WHO (2020) Progress on drinking water, sanitation, and hygiene in schools: Special focus on COVID-19. ** Essity (2022) Global Hygiene and Health Survey 2022: The Future of Well-being.*** Brody, J. E. (2008, November 10). When Families Take Care of Their Own. The New York Times.**** Human Capital Hub (2022). Absenteeism in the workplace: Impact, causes, and policies. Human Capital Hub. * UNICEF and WHO (2020) Progress on drinking water, sanitation, and hygiene in schools: Special...
PR Newswire
29/08/2023

Orexo secures patent protection in the US for OX640, a nasal epinephrine powder…

Nikolaj Sørensen, President and CEO, said: "OX640 is truly a unique and innovative new product to be used for the emergency treatment of allergic reactions. I am pleased that this innovation has been recognized by the USPTO, an important step towards making this life-saving medication available for patients in the US. OX640 has shown astonishing chemical stability, impressive clinical data, and has significant global market potential. The strong patent portfolio covering OX640 is clearly a…
PR Newswire
29/08/2023

Mendus AB (publ) Interim Report January – June 2023

“In the second quarter of 2023, Mendus' main objectives were focused on driving the evolution of our pipeline and securing the related financing. The progress made in the previous quarters, including the positive survival data of the ADVANCE II trial, improvements of our production processes and adjusting our strategy to the rapidly evolving cancer therapy landscape, provided the basis for a next financing round, which we announced last June. The directed placement and rights issue totaling...
Nasdaq GlobeNewswire
29/08/2023

European Commission approves Roche's Evrysdi for babies under two months old…

Evrysdi available to treat people of all ages with SMA in the European Union, including babies from birth 1 Approval is based on interim data from ongoing RAINBOWFISH trial showing majority of Evrysdi-treated babies were able to stand and walk within timeframes typical of healthy babies by 12 months' treatment 2,3 Evrysdi is the only non-invasive SMA therapy and is approved in 100 countries with more than 11,000 patients treated globallyBasel, 29 August 2023 - Roche...
Nasdaq GlobeNewswire
29/08/2023

Health Canada Accepts Valneva's Chikungunya Vaccine License Application for…

Saint-Herblain(France), August29 , 2023–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that Health Canada has completed screening validation of the Company's regulatory application for marketing approval of its single-shot chikungunya vaccine candidate VLA1553 in persons aged 18 years and above, and has determined that the New Drug Submission (NDS) application is sufficiently complete to permit a substantive review...
Nasdaq GlobeNewswire
29/08/2023

Fertility Supplement Global Market to Exhibit Growth at a CAGR of ~8% by 2028 |…

Key Takeaways from the Fertility Supplement Market Report Key Takeaways from the Fertility Supplement Market Report To read more about the latest highlights related to the fertility supplement market, get a snapshot of the key highlights entailed in theGlobal Fertility Supplement Market Report Fertility Supplement Overview Fertility supplements are specialized products designed to support and enhance reproductive health in both men and women. These supplements often contain...
PR Newswire
28/08/2023
Altri  Comunicati